Sarepta Therapeutics, Inc. (SRPT)

17.16 -1.81 (-9.54%) USD  |  NASDAQ  |  Feb 26, 13:54
More

Sarepta Therapeutics Accrued Expenses (Quarterly)

Accrued Expenses (Quarterly) Chart

View Accrued Expenses (Quarterly) for SRPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Accrued Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Accrued Expenses (Quarterly) Range, Past 5 Years

View Accrued Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Accrued Expenses (Quarterly) Benchmarks

View Accrued Expenses (Quarterly) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. Upgrade
Merck & Co., Inc. Upgrade
Pfizer Inc. --
REGENXBIO, Inc. Upgrade
Keros Therapeutics, Inc. Upgrade